He joined LSUHSC at Shreveport in 2002 after completing a clinical fellowship in surgical oncology at Roswell Park Cancer Institute in Buffalo, NY. Dr. Chu's clinical interests include the management of patients with cancer of the gastrointestinal tract (esophagus, stomach, liver, bile ducts, pancreas, colon and rectum), breast cancer, melanoma, thyroid and parathyroid tumors, and soft tissue tumors (retroperitoneal tumors and extremity sarcomas). He has been instrumental in establishing two life-saving programs: Hyperthermic Intraperitoneal Chemotherapy (HIPEC) program for advanced abdominal malignancies and mammosite for breast cancer patients. He has also helped in the development of novel therapies, such as gene therapy, to treat patients with advanced solid malignancies.